文献速递糖尿病肥胖与代谢综合征

KLF10转录因子调控小鼠肝脏葡萄糖代谢

KLF10 transcription factor regulates hepatic glucose metabolism in mice.
PubMed 文献 · Diabetologia · 2017-08-23

研究探索Krüppel样因子10(KLF10)在小鼠肝脏葡萄糖代谢中的生理作用。在野生型、糖尿病、肥胖及高脂饮食诱导肥胖小鼠中检测肝脏KLF10表达,并通过腺病毒过表达或敲低KLF10,观察糖异生基因表达、血糖及葡萄糖耐量变化。结果显示KLF10通过直接结合Pgc-1α启动子激活其转录,过表达升高血糖并损害糖耐量,敲低则降低糖尿病和肥胖小鼠血糖并改善糖耐量。

要点

  • 肝脏KLF10表达受营养状态调控,在糖尿病、肥胖及高脂饮食诱导肥胖小鼠中上调。
  • 肝脏过表达KLF10升高血糖并损害糖耐量,敲低KLF10降低db/db和DIO小鼠血糖并改善糖耐量。
  • KLF10通过直接结合Pgc-1α启动子区域激活其转录。

核心结论

  • KLF10是肝脏葡萄糖代谢的重要调控因子。
  • 调节肝脏KLF10表达可能是治疗2型糖尿病的有吸引力的方法。

研究设计与样本

  • 在野生型C57BL/6J小鼠、db/db糖尿病小鼠模型、ob/ob肥胖小鼠模型和高脂饮食诱导肥胖(DIO)小鼠中检测肝脏KLF10表达。
  • 向野生型C57BL/6J小鼠、db/db或DIO小鼠注射表达Klf10或Klf10特异性短发夹RNA的腺病毒。
  • 检测肝脏糖异生基因表达和血糖水平,并进行葡萄糖耐量试验和丙酮酸耐量试验。
  • 探索KLF10调控肝脏葡萄糖代谢的分子机制。

主要发现

  • 野生型小鼠肝脏KLF10表达受营养状态调控,在糖尿病、肥胖和DIO小鼠中上调。
  • 原代肝细胞中过表达KLF10增加糖异生基因表达和细胞葡萄糖输出。
  • 肝脏过表达KLF10的C57BL/6J小鼠血糖水平升高且葡萄糖耐量受损。
  • db/db和DIO小鼠中肝脏敲低KLF10降低血糖水平并改善葡萄糖耐量。
  • 荧光素酶报告基因试验和染色质免疫沉淀分析表明KLF10通过直接结合Pgc-1α(又称Ppargc1a)基因启动子区域激活其转录。

临床怎么用

  • 原文结论指出调节肝脏KLF10表达可能是治疗2型糖尿病的有吸引力的方法,未给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM/HYPOTHESIS: Abnormal activation of hepatic gluconeogenesis leads to hyperglycaemia. However, the molecular mechanisms underlying dysregulated hepatic gluconeogenesis remain to be fully defined. Here, we explored the physiological role of Krüppel-like factor 10 (KLF10) in regulating hepatic glucose metabolism in mice. METHODS: Hepatic KLF10 expression in wild-type C57BL/6J mice, the db/db mouse model of diabetes, the ob/ob mouse model of obesity and high-fat-diet-induced obese (DIO) mice was measured. Adenoviruses expressing Klf10 or Klf10-specific short-hairpin RNA were injected into wild-type C57BL/6J mice, db/db or DIO mice. Expression of gluconeogenic genes in the liver and blood glucose levels were measured. GTTs and pyruvate tolerance tests were performed. The molecular mechanism by which KLF10 regulates hepatic glucose metabolism was explored. RESULTS: Hepatic KLF10 expression was regulated by nutritional status in wild-type mice and upregulated in diabetic, obese and DIO mice. Overexpression of KLF10 in primary hepatocytes increased the expression of gluconeogenic genes and cellular glucose output. C57BL/6J mice with KLF10 overexpression in the liver displayed increased blood glucose levels and impaired glucose tolerance. Conversely, hepatic KLF10 knockdown in db/db and DIO mice decreased blood glucose levels and improved glucose tolerance. Furthermore, luciferase reporter gene assay and chromatin immunoprecipitation analysis indicated that KLF10 activates Pgc-1α (also known as Ppargc1a) gene transcription via directly binding to its promoter region. CONCLUSIONS/INTERPRETATION: KLF10 is an important regulator of hepatic glucose metabolism and modulation of KLF10 expression in the liver may be an attractive approach for the treatment of type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Yang X, Chen Q, Sun L, et al. KLF10 transcription factor regulates hepatic glucose metabolism in mice. Diabetologia. 2017. PMID: 28836014. doi:10.1007/s00125-017-4412-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。